GABAergic Signaling as Therapeutic Target for Autism Spectrum Disorders

γ-Aminobutyric acid (GABA), the main inhibitory neurotransmitter in the adult brain, early in postnatal life exerts a depolarizing and excitatory action. This depends on accumulation of chloride inside the cell via the cation–chloride importer NKCC1, being the expression of the chloride exporter KCC2 very low at birth. The developmentally regulated expression of KCC2 results in extrusion of chloride with age and a shift of GABA from the depolarizing to the hyperpolarizing direction. The depolarizing action of GABA leads to intracellular calcium rise through voltage-dependent calcium channels and/or N-methyl-d-aspartate receptors. GABA-mediated calcium signals regulate a variety of developmental processes from cell proliferation migration, differentiation, synapse maturation, and neuronal wiring. Therefore, it is not surprising that some forms of neuro-developmental disorders such as autism spectrum disorders (ASDs) are associated with alterations of GABAergic signaling and impairment of the excitatory/inhibitory balance in selective neuronal circuits. In this review, we will discuss how changes of GABAA-mediated neurotransmission affect several forms of ASDs including the Fragile X, the Angelman, and Rett syndromes. Then, we will describe various animal models of ASDs with GABAergic dysfunctions, highlighting their behavioral deficits and the possibility to rescue them by targeting selective components of the GABAergic synapse. In particular, we will discuss how in some cases, reverting the polarity of GABA responses from the depolarizing to the hyperpolarizing direction with the diuretic bumetanide, a selective blocker of NKCC1, may have beneficial effects on ASDs, thus opening new therapeutic perspectives for the treatment of these devastating disorders.

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  Nouchine Hadjikhani,et al.  Improving emotional face perception in autism with diuretic bumetanide: A proof-of-concept behavioral and functional brain imaging pilot study , 2015, Autism : the international journal of research and practice.

[3]  Giada Cellot,et al.  Reduced inhibitory gate in the barrel cortex of Neuroligin3R451C knock‐in mice, an animal model of autism spectrum disorders , 2014, Physiological reports.

[4]  William A. Catterall,et al.  Enhancement of Inhibitory Neurotransmission by GABAA Receptors Having α2,3-Subunits Ameliorates Behavioral Deficits in a Mouse Model of Autism , 2014, Neuron.

[5]  Amene Shahrokhi,et al.  Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring , 2014, Science.

[6]  Donald C. Rojas,et al.  Decreased left perisylvian GABA concentration in children with autism and unaffected siblings , 2014, NeuroImage.

[7]  David R. O'Brien,et al.  Cell Type-Specific Expression Analysis to Identify Putative Cellular Mechanisms for Neurogenetic Disorders , 2014, The Journal of Neuroscience.

[8]  A. Joyner,et al.  Loss of GABAergic neurons in the hippocampus and cerebral cortex of Engrailed-2 null mutant mice: Implications for autism spectrum disorders , 2013, Experimental Neurology.

[9]  S. Duarte,et al.  Abnormal Expression of Cerebrospinal Fluid Cation Chloride Cotransporters in Patients with Rett Syndrome , 2013, PloS one.

[10]  M. Kilgard,et al.  Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism. , 2013, The international journal of neuropsychopharmacology.

[11]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[12]  M. Casanova,et al.  A Review of Traditional and Novel Treatments for Seizures in Autism Spectrum Disorder: Findings from a Systematic Review and Expert Panel , 2013, Front. Public Health.

[13]  J. Tiago Gonçalves,et al.  Circuit level defects in the developing neocortex of fragile X mice , 2013, Nature Neuroscience.

[14]  T. Südhof,et al.  Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling , 2013, Neuron.

[15]  Weiwei Zhong,et al.  GABAergic synaptic inputs of locus coeruleus neurons in wild-type and Mecp2-null mice. , 2013, American journal of physiology. Cell physiology.

[16]  Declan Murphy,et al.  The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [11C]Ro15-4513 positron emission tomography study , 2013, Neuropharmacology.

[17]  K. Meador,et al.  Risks of in utero exposure to valproate. , 2013, JAMA.

[18]  E. Cherubini,et al.  Developmental regulation of GABAergic signalling in the hippocampus of neuroligin 3 R451C knock-in mice: an animal model of Autism , 2013, Front. Cell. Neurosci..

[19]  M. Kitagawa,et al.  Decreased Tonic Inhibition in Cerebellar Granule Cells Causes Motor Dysfunction in a Mouse Model of Angelman Syndrome , 2012, Science Translational Medicine.

[20]  Y. Ben-Ari,et al.  A randomised controlled trial of bumetanide in the treatment of autism in children , 2012, Translational Psychiatry.

[21]  L. Oberman.  mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders , 2012, Expert opinion on investigational drugs.

[22]  Rodney C. Samaco,et al.  Preclinical research in Rett syndrome: setting the foundation for translational success , 2012, Disease Models & Mechanisms.

[23]  David J. Nutt,et al.  GABA system dysfunction in autism and related disorders: From synapse to symptoms , 2012, Neuroscience & Biobehavioral Reviews.

[24]  M. Bear,et al.  Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial , 2012, Science Translational Medicine.

[25]  S. Kagami,et al.  Evaluation of the GABAergic nervous system in autistic brain: 123I-iomazenil SPECT study , 2012, Brain and Development.

[26]  Heiko J. Luhmann,et al.  Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever! , 2012, Front. Cell. Neurosci..

[27]  W. Singer,et al.  Impaired Gamma-Band Activity during Perceptual Organization in Adults with Autism Spectrum Disorders: Evidence for Dysfunctional Network Activity in Frontal-Posterior Cortices , 2012, The Journal of Neuroscience.

[28]  William A Catterall,et al.  Autistic behavior in Scn1a+/− mice and rescue by enhanced GABAergic transmission , 2012, Nature.

[29]  M. Avoli,et al.  Jasper's basic mechanisms of the epilepsies , 2012 .

[30]  D. Hochman,et al.  The extracellular space and epileptic activity in the adult brain: Explaining the antiepileptic effects of furosemide and bumetanide , 2012, Epilepsia.

[31]  Annapurna Poduri,et al.  Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia , 2012, Annals of neurology.

[32]  Mark F Bear,et al.  Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. , 2012, Cold Spring Harbor perspectives in biology.

[33]  M. Huntsman,et al.  Fragile X Syndrome: The GABAergic System and Circuit Dysfunction , 2011, Developmental Neuroscience.

[34]  Thomas C. Südhof,et al.  Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function , 2011, Proceedings of the National Academy of Sciences.

[35]  Enrico Cherubini,et al.  Alterations of GABAergic Signaling in Autism Spectrum Disorders , 2011, Neural plasticity.

[36]  Kenji Mori,et al.  Non-Invasive Evaluation of the GABAergic/Glutamatergic System in Autistic Patients Observed by MEGA-Editing Proton MR Spectroscopy Using a Clinical 3 Tesla Instrument , 2011, Journal of autism and developmental disorders.

[37]  E. Cherubini,et al.  The Depolarizing Action of GABA Controls Early Network Activity in the Developing Hippocampus , 2011, Molecular Neurobiology.

[38]  Y. Ben-Ari,et al.  The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects , 2010, Acta paediatrica.

[39]  Rodney C. Samaco,et al.  GABAergic dysfunction mediates autism-like stereotypies and Rett syndrome phenotypes , 2010, Nature.

[40]  G. Blatt,et al.  Decreased GABAB receptors in the cingulate cortex and fusiform gyrus in Autism , 2010, Journal of neurochemistry.

[41]  W. Kaufmann,et al.  Defective GABAergic Neurotransmission and Pharmacological Rescue of Neuronal Hyperexcitability in the Amygdala in a Mouse Model of Fragile X Syndrome , 2010, The Journal of Neuroscience.

[42]  R. Hagerman,et al.  Fragile X: Leading the way for targeted treatments in autism , 2010, Neurotherapeutics.

[43]  B. Alger,et al.  Enhanced Endocannabinoid Signaling Elevates Neuronal Excitability in Fragile X Syndrome , 2010, The Journal of Neuroscience.

[44]  D. Kunze,et al.  Exogenous Brain-Derived Neurotrophic Factor Rescues Synaptic Dysfunction in Mecp2-Null Mice , 2010, The Journal of Neuroscience.

[45]  R. Khazipov,et al.  Temporal Coding at the Immature Depolarizing GABAergic Synapse , 2010, Frontiers in Cellular Neuroscience.

[46]  Zhong-Wei Zhang,et al.  MeCP2 is required for normal development of GABAergic circuits in the thalamus. , 2010, Journal of neurophysiology.

[47]  T. Kemper,et al.  Parvalbumin‐, calbindin‐, and calretinin‐immunoreactive hippocampal interneuron density in autism , 2010, Acta neurologica Scandinavica.

[48]  Jang-Yen Wu,et al.  A novel mechanism for GABA synthesis and packaging into synaptic vesicles , 2009, Neurochemistry International.

[49]  G. Blatt,et al.  Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism , 2009, Autism research : official journal of the International Society for Autism Research.

[50]  Philippe Séguéla,et al.  Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. , 2009, Cerebral cortex.

[51]  K. Deisseroth,et al.  Parvalbumin neurons and gamma rhythms enhance cortical circuit performance , 2009, Nature.

[52]  T. Südhof,et al.  Common circuit defect of excitatory-inhibitory balance in mouse models of autism , 2009, Journal of Neurodevelopmental Disorders.

[53]  A. Dicko,et al.  A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali. , 2009, Vaccine.

[54]  A. Kriegstein,et al.  Defining the role of GABA in cortical development , 2009, The Journal of physiology.

[55]  F. Vaglini,et al.  Increased susceptibility to kainic acid–induced seizures in Engrailed-2 knockout mice , 2009, Neuroscience.

[56]  Nathan R. Wilson,et al.  Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice , 2009, Proceedings of the National Academy of Sciences.

[57]  Bassem A. Hassan,et al.  Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS) , 2009, Brain Research.

[58]  G. Blatt,et al.  Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study , 2009, Autism research : official journal of the International Society for Autism Research.

[59]  J. Gibson,et al.  Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome. , 2008, Journal of neurophysiology.

[60]  Maurizio Taglialatela,et al.  Low expression of Kv7/M channels facilitates intrinsic and network bursting in the developing rat hippocampus , 2008, The Journal of physiology.

[61]  T. Südhof.  Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.

[62]  C. Chien,et al.  Fak56 functions downstream of integrin alphaPS3betanu and suppresses MAPK activation in neuromuscular junction growth , 2008, Neural Development.

[63]  P. Somogyi,et al.  Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations , 2008, Science.

[64]  Douglas L. Rosene,et al.  Cerebellar Purkinje Cells are Reduced in a Subpopulation of Autistic Brains: A Stereological Experiment Using Calbindin-D28k , 2008, The Cerebellum.

[65]  P. Calabresi,et al.  Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome , 2008, Biological Psychiatry.

[66]  Liang Zhang,et al.  The MeCP2‐null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability , 2008, Hippocampus.

[67]  G. Blatt,et al.  Increased GAD67 mRNA expression in cerebellar interneurons in autism: Implications for Purkinje cell dysfunction , 2008, Journal of neuroscience research.

[68]  Anamaria Sudarov,et al.  Cerebellum morphogenesis: the foliation pattern is orchestrated by multi-cellular anchoring centers , 2007, Neural Development.

[69]  Jacqueline Blundell,et al.  A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice , 2007, Science.

[70]  R. Khazipov,et al.  GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. , 2007, Physiological reviews.

[71]  E. Cherubini,et al.  Correlated network activity enhances synaptic efficacy via BDNF and the ERK pathway at immature CA3–CA1 connections in the hippocampus , 2007, Proceedings of the National Academy of Sciences.

[72]  R. Khazipov,et al.  Maternal Oxytocin Triggers a Transient Inhibitory Switch in GABA Signaling in the Fetal Brain During Delivery , 2006, Science.

[73]  E. Cherubini,et al.  In the developing rat hippocampus a tonic GABAA‐mediated conductance selectively enhances the glutamatergic drive of principal cells , 2007, The Journal of physiology.

[74]  M. Poo,et al.  Excitatory GABA Action Is Essential for Morphological Maturation of Cortical Neurons In Vivo , 2007, The Journal of Neuroscience.

[75]  T. Kemper,et al.  [3H]-Flunitrazepam-labeled Benzodiazepine Binding Sites in the Hippocampal Formation in Autism: A Multiple Concentration Autoradiographic Study , 2007, Journal of autism and developmental disorders.

[76]  A. Bird,et al.  Reversal of Neurological Defects in a Mouse Model of Rett Syndrome , 2007, Science.

[77]  R. Jaenisch,et al.  Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2 , 2007, Proceedings of the National Academy of Sciences.

[78]  Qian-Quan Sun,et al.  Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein , 2007, Neuroscience Letters.

[79]  G. Blatt,et al.  Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications , 2007, Acta Neuropathologica.

[80]  J. Millonig,et al.  En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder , 2006, Brain Research.

[81]  W. Singer,et al.  Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology , 2006, Neuron.

[82]  Juha Voipio,et al.  Intrinsic bursting of immature CA3 pyramidal neurons and consequent giant depolarizing potentials are driven by a persistent Na+ current and terminated by a slow Ca2+‐activated K+ current , 2006, The European journal of neuroscience.

[83]  K. Reuhl,et al.  A New Neurobehavioral Model of Autism in Mice: Pre- and Postnatal Exposure to Sodium Valproate , 2006, Journal of autism and developmental disorders.

[84]  R. D'Hooge,et al.  Expression profiling suggests underexpression of the GABAA receptor subunit δ in the fragile X knockout mouse model , 2006, Neurobiology of Disease.

[85]  Ivan Cohen,et al.  Threshold Behavior in the Initiation of Hippocampal Population Bursts , 2006, Neuron.

[86]  F. Jensen,et al.  NKCC1 transporter facilitates seizures in the developing brain , 2005, Nature Medicine.

[87]  Rudolf Jaenisch,et al.  Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[88]  I. Soltesz,et al.  Depolarizing GABA Acts on Intrinsically Bursting Pyramidal Neurons to Drive Giant Depolarizing Potentials in the Immature Hippocampus , 2005, The Journal of Neuroscience.

[89]  Y. Ben-Ari,et al.  A Noncanonical Release of GABA and Glutamate Modulates Neuronal Migration , 2005, The Journal of Neuroscience.

[90]  Hiroki Toyoda,et al.  Cl− uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1 , 2004, The Journal of physiology.

[91]  Y. Yaari,et al.  KCNQ/M Channels Control Spike Afterdepolarization and Burst Generation in Hippocampal Neurons , 2004, The Journal of Neuroscience.

[92]  E. Cherubini,et al.  GABA-mediated giant depolarizing potentials as coincidence detectors for enhancing synaptic efficacy in the developing hippocampus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[93]  D. Buxhoeveden,et al.  Disruption in the Inhibitory Architecture of the Cell Minicolumn: Implications for Autisim , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[94]  Thomas Bourgeron,et al.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism , 2003, Nature Genetics.

[95]  G. Homanics,et al.  Mouse models of Angelman syndrome, a neurodevelopmental disorder, display different brain regional GABAA receptor alterations , 2003, Neuroscience Letters.

[96]  M A Pericak-Vance,et al.  Fine mapping of autistic disorder to chromosome 15q11‐q13 by use of phenotypic subtypes. , 2003, American journal of human genetics.

[97]  Y. Ben-Ari,et al.  Paracrine Intercellular Communication by a Ca2+- and SNARE-Independent Release of GABA and Glutamate Prior to Synapse Formation , 2002, Neuron.

[98]  S. Schulz,et al.  Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices , 2002, Biological Psychiatry.

[99]  G. Buzsáki,et al.  Correlated Bursts of Activity in the Neonatal Hippocampus in Vivo , 2002, Science.

[100]  Nicholas C Spitzer,et al.  Activity-dependent neuronal differentiation prior to synapse formation: the functions of calcium transients , 2002, Journal of Physiology-Paris.

[101]  Andrew E. Switala,et al.  Minicolumnar pathology in autism , 2002, Neurology.

[102]  D. Buxhoeveden,et al.  Asperger's Syndrome and Cortical Neuropathology , 2002, Journal of child neurology.

[103]  T. Kemper,et al.  Density and Distribution of Hippocampal Neurotransmitter Receptors in Autism: An Autoradiographic Study , 2001, Journal of autism and developmental disorders.

[104]  P. Chiurazzi,et al.  The fragile X gene and its function , 2001, Clinical genetics.

[105]  R. Jaenisch,et al.  Expression Pattern of the Rett Syndrome Gene MeCP2 in Primate Prefrontal Cortex , 2001, Neurobiology of Disease.

[106]  R. Tuchman,et al.  Antiepileptic drugs: affective use in autism spectrum disorders. , 2001, Pediatric neurology.

[107]  L. Nguyen,et al.  Neurotransmitters as early signals for central nervous system development , 2001, Cell and Tissue Research.

[108]  M. Kneussel,et al.  Receptors, gephyrin and gephyrin‐associated proteins: novel insights into the assembly of inhibitory postsynaptic membrane specializations , 2000, The Journal of physiology.

[109]  L. M. Prida,et al.  Heterogeneous populations of cells mediate spontaneous synchronous bursting in the developing hippocampus through a frequency-dependent mechanism , 2000, Neuroscience.

[110]  I. Jambaqué,et al.  Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients , 2000, Epilepsy Research.

[111]  Yehezkel Ben-Ari,et al.  The Establishment of GABAergic and Glutamatergic Synapses on CA1 Pyramidal Neurons is Sequential and Correlates with the Development of the Apical Dendrite , 1999, The Journal of Neuroscience.

[112]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[113]  J. A. Payne,et al.  The K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation , 1999, Nature.

[114]  G. Buzsáki,et al.  Interneurons of the hippocampus , 1998, Hippocampus.

[115]  P. Rakic,et al.  Orchestration of neuronal migration by activity of ion channels, neurotransmitter receptors, and intracellular Ca2+ fluctuations. , 1998, Journal of neurobiology.

[116]  J. Barker,et al.  Differential Response of Cortical Plate and Ventricular Zone Cells to GABA as a Migration Stimulus , 1998, The Journal of Neuroscience.

[117]  Stephen J. Guter,et al.  Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. , 1998, American journal of human genetics.

[118]  Y. Yonekura,et al.  Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome , 1998, Journal of the Neurological Sciences.

[119]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[120]  P. Plouin,et al.  Atlas of neonatal electroencephalography, éd, Stockard-Pope JE, Werner SS, Bickford RG. Raven Press, Paris (1992), 400 p. , 1992 .

[121]  Y. Ben-Ari,et al.  GABA: an excitatory transmitter in early postnatal life , 1991, Trends in Neurosciences.

[122]  Y. Ben-Ari,et al.  Giant synaptic potentials in immature rat CA3 hippocampal neurones. , 1989, The Journal of physiology.

[123]  F. Marrosu,et al.  Paradoxical reactions elicited by diazepam in children with classic autism. , 1987, Functional neurology.

[124]  T. Kemper,et al.  Histoanatomic observations of the brain in early infantile autism , 1985, Neurology.

[125]  R. S. Williams,et al.  Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior. , 1980, Archives of neurology.

[126]  J Priestley,et al.  An Account of the Anatomy and Physiology of Batrachian Lymph‐Hearts (mainly Bibliographical) , 1878, The Journal of physiology.

[127]  M. Avoli,et al.  Phasic GABAA-Mediated Inhibition -- Jasper's Basic Mechanisms of the Epilepsies , 2012 .

[128]  M. Missler,et al.  Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. , 2008, Journal of neurophysiology.

[129]  M. Sibony,et al.  An In Situ Hybridization Study , 2005 .

[130]  D. Kwiatkowski,et al.  Tuberous sclerosis. , 1994, Archives of dermatology.